1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Immunochemistry 1.2.3 Molecular Diagnostics 1.3 Market by Application 1.3.1 Global IVD Infectious Diseases Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Clinical Laboratories 1.3.3 Diagnostic Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global IVD Infectious Diseases Market Perspective (2016-2027) 2.2 IVD Infectious Diseases Growth Trends by Regions 2.2.1 IVD Infectious Diseases Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 IVD Infectious Diseases Historic Market Share by Regions (2016-2021) 2.2.3 IVD Infectious Diseases Forecasted Market Size by Regions (2022-2027) 2.3 IVD Infectious Diseases Industry Dynamic 2.3.1 IVD Infectious Diseases Market Trends 2.3.2 IVD Infectious Diseases Market Drivers 2.3.3 IVD Infectious Diseases Market Challenges 2.3.4 IVD Infectious Diseases Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top IVD Infectious Diseases Players by Revenue 3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2016-2021) 3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2016-2021) 3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by IVD Infectious Diseases Revenue 3.4 Global IVD Infectious Diseases Market Concentration Ratio 3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2020 3.5 IVD Infectious Diseases Key Players Head office and Area Served 3.6 Key Players IVD Infectious Diseases Product Solution and Service 3.7 Date of Enter into IVD Infectious Diseases Market 3.8 Mergers & Acquisitions, Expansion Plans 4 IVD Infectious Diseases Breakdown Data by Type 4.1 Global IVD Infectious Diseases Historic Market Size by Type (2016-2021) 4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2022-2027) 5 IVD Infectious Diseases Breakdown Data by Application 5.1 Global IVD Infectious Diseases Historic Market Size by Application (2016-2021) 5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America IVD Infectious Diseases Market Size (2016-2027) 6.2 North America IVD Infectious Diseases Market Size by Type 6.2.1 North America IVD Infectious Diseases Market Size by Type (2016-2021) 6.2.2 North America IVD Infectious Diseases Market Size by Type (2022-2027) 6.2.3 North America IVD Infectious Diseases Market Size by Type (2016-2027) 6.3 North America IVD Infectious Diseases Market Size by Application 6.3.1 North America IVD Infectious Diseases Market Size by Application (2016-2021) 6.3.2 North America IVD Infectious Diseases Market Size by Application (2022-2027) 6.3.3 North America IVD Infectious Diseases Market Size by Application (2016-2027) 6.4 North America IVD Infectious Diseases Market Size by Country 6.4.1 North America IVD Infectious Diseases Market Size by Country (2016-2021) 6.4.2 North America IVD Infectious Diseases Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe IVD Infectious Diseases Market Size (2016-2027) 7.2 Europe IVD Infectious Diseases Market Size by Type 7.2.1 Europe IVD Infectious Diseases Market Size by Type (2016-2021) 7.2.2 Europe IVD Infectious Diseases Market Size by Type (2022-2027) 7.2.3 Europe IVD Infectious Diseases Market Size by Type (2016-2027) 7.3 Europe IVD Infectious Diseases Market Size by Application 7.3.1 Europe IVD Infectious Diseases Market Size by Application (2016-2021) 7.3.2 Europe IVD Infectious Diseases Market Size by Application (2022-2027) 7.3.3 Europe IVD Infectious Diseases Market Size by Application (2016-2027) 7.4 Europe IVD Infectious Diseases Market Size by Country 7.4.1 Europe IVD Infectious Diseases Market Size by Country (2016-2021) 7.4.2 Europe IVD Infectious Diseases Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific IVD Infectious Diseases Market Size (2016-2027) 8.2 Asia-Pacific IVD Infectious Diseases Market Size by Type 8.2.1 Asia-Pacific IVD Infectious Diseases Market Size by Type (2016-2021) 8.2.2 Asia-Pacific IVD Infectious Diseases Market Size by Type (2022-2027) 8.2.3 Asia-Pacific IVD Infectious Diseases Market Size by Type (2016-2027) 8.3 Asia-Pacific IVD Infectious Diseases Market Size by Application 8.3.1 Asia-Pacific IVD Infectious Diseases Market Size by Application (2016-2021) 8.3.2 Asia-Pacific IVD Infectious Diseases Market Size by Application (2022-2027) 8.3.3 Asia-Pacific IVD Infectious Diseases Market Size by Application (2016-2027) 8.4 Asia-Pacific IVD Infectious Diseases Market Size by Region 8.4.1 Asia-Pacific IVD Infectious Diseases Market Size by Region (2016-2021) 8.4.2 Asia-Pacific IVD Infectious Diseases Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America IVD Infectious Diseases Market Size (2016-2027) 9.2 Latin America IVD Infectious Diseases Market Size by Type 9.2.1 Latin America IVD Infectious Diseases Market Size by Type (2016-2021) 9.2.2 Latin America IVD Infectious Diseases Market Size by Type (2022-2027) 9.2.3 Latin America IVD Infectious Diseases Market Size by Type (2016-2027) 9.3 Latin America IVD Infectious Diseases Market Size by Application 9.3.1 Latin America IVD Infectious Diseases Market Size by Application (2016-2021) 9.3.2 Latin America IVD Infectious Diseases Market Size by Application (2022-2027) 9.3.3 Latin America IVD Infectious Diseases Market Size by Application (2016-2027) 9.4 Latin America IVD Infectious Diseases Market Size by Country 9.4.1 Latin America IVD Infectious Diseases Market Size by Country (2016-2021) 9.4.2 Latin America IVD Infectious Diseases Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa IVD Infectious Diseases Market Size (2016-2027) 10.2 Middle East & Africa IVD Infectious Diseases Market Size by Type 10.2.1 Middle East & Africa IVD Infectious Diseases Market Size by Type (2016-2021) 10.2.2 Middle East & Africa IVD Infectious Diseases Market Size by Type (2022-2027) 10.2.3 Middle East & Africa IVD Infectious Diseases Market Size by Type (2016-2027) 10.3 Middle East & Africa IVD Infectious Diseases Market Size by Application 10.3.1 Middle East & Africa IVD Infectious Diseases Market Size by Application (2016-2021) 10.3.2 Middle East & Africa IVD Infectious Diseases Market Size by Application (2022-2027) 10.3.3 Middle East & Africa IVD Infectious Diseases Market Size by Application (2016-2027) 10.4 Middle East & Africa IVD Infectious Diseases Market Size by Country 10.4.1 Middle East & Africa IVD Infectious Diseases Market Size by Country (2016-2021) 10.4.2 Middle East & Africa IVD Infectious Diseases Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BD 11.1.1 BD Company Details 11.1.2 BD Business Overview 11.1.3 BD IVD Infectious Diseases Introduction 11.1.4 BD Revenue in IVD Infectious Diseases Business (2016-2021) 11.1.5 BD Recent Development 11.2 BioMerieux 11.2.1 BioMerieux Company Details 11.2.2 BioMerieux Business Overview 11.2.3 BioMerieux IVD Infectious Diseases Introduction 11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2016-2021) 11.2.5 BioMerieux Recent Development 11.3 Abbott 11.3.1 Abbott Company Details 11.3.2 Abbott Business Overview 11.3.3 Abbott IVD Infectious Diseases Introduction 11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2016-2021) 11.3.5 Abbott Recent Development 11.4 Quidel 11.4.1 Quidel Company Details 11.4.2 Quidel Business Overview 11.4.3 Quidel IVD Infectious Diseases Introduction 11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2016-2021) 11.4.5 Quidel Recent Development 11.5 Gen-Probe 11.5.1 Gen-Probe Company Details 11.5.2 Gen-Probe Business Overview 11.5.3 Gen-Probe IVD Infectious Diseases Introduction 11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2016-2021) 11.5.5 Gen-Probe Recent Development 11.6 Abbott 11.6.1 Abbott Company Details 11.6.2 Abbott Business Overview 11.6.3 Abbott IVD Infectious Diseases Introduction 11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2016-2021) 11.6.5 Abbott Recent Development 11.7 Danaher 11.7.1 Danaher Company Details 11.7.2 Danaher Business Overview 11.7.3 Danaher IVD Infectious Diseases Introduction 11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2016-2021) 11.7.5 Danaher Recent Development 11.8 Sysmex 11.8.1 Sysmex Company Details 11.8.2 Sysmex Business Overview 11.8.3 Sysmex IVD Infectious Diseases Introduction 11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2016-2021) 11.8.5 Sysmex Recent Development 11.9 Orasure 11.9.1 Orasure Company Details 11.9.2 Orasure Business Overview 11.9.3 Orasure IVD Infectious Diseases Introduction 11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2016-2021) 11.9.5 Orasure Recent Development 11.10 Hologic 11.10.1 Hologic Company Details 11.10.2 Hologic Business Overview 11.10.3 Hologic IVD Infectious Diseases Introduction 11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2016-2021) 11.10.5 Hologic Recent Development 11.11 Cepheid 11.11.1 Cepheid Company Details 11.11.2 Cepheid Business Overview 11.11.3 Cepheid IVD Infectious Diseases Introduction 11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2016-2021) 11.11.5 Cepheid Recent Development 11.12 Qiagen 11.12.1 Qiagen Company Details 11.12.2 Qiagen Business Overview 11.12.3 Qiagen IVD Infectious Diseases Introduction 11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2016-2021) 11.12.5 Qiagen Recent Development 11.13 Roche Diagnostics 11.13.1 Roche Diagnostics Company Details 11.13.2 Roche Diagnostics Business Overview 11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction 11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2016-2021) 11.13.5 Roche Diagnostics Recent Development 11.14 Siemens Healthcare 11.14.1 Siemens Healthcare Company Details 11.14.2 Siemens Healthcare Business Overview 11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction 11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2016-2021) 11.14.5 Siemens Healthcare Recent Development 11.15 Bio-Rad Laboratories 11.15.1 Bio-Rad Laboratories Company Details 11.15.2 Bio-Rad Laboratories Business Overview 11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction 11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2016-2021) 11.15.5 Bio-Rad Laboratories Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Immunochemistry Table 3. Key Players of Molecular Diagnostics Table 4. Global IVD Infectious Diseases Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global IVD Infectious Diseases Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global IVD Infectious Diseases Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global IVD Infectious Diseases Market Share by Regions (2016-2021) Table 8. Global IVD Infectious Diseases Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global IVD Infectious Diseases Market Share by Regions (2022-2027) Table 10. IVD Infectious Diseases Market Trends Table 11. IVD Infectious Diseases Market Drivers Table 12. IVD Infectious Diseases Market Challenges Table 13. IVD Infectious Diseases Market Restraints Table 14. Global IVD Infectious Diseases Revenue by Players (2016-2021) & (US$ Million) Table 15. Global IVD Infectious Diseases Market Share by Players (2016-2021) Table 16. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Diseases as of 2020) Table 17. Ranking of Global Top IVD Infectious Diseases Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players IVD Infectious Diseases Product Solution and Service Table 21. Date of Enter into IVD Infectious Diseases Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million) Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2016-2021) Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global IVD Infectious Diseases Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global IVD Infectious Diseases Revenue Market Share by Application (2016-2021) Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global IVD Infectious Diseases Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million) Table 32. North America IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million) Table 33. North America IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million) Table 34. North America IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million) Table 35. North America IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) Table 36. North America IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million) Table 38. Europe IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million) Table 40. Europe IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific IVD Infectious Diseases Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific IVD Infectious Diseases Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa IVD Infectious Diseases Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa IVD Infectious Diseases Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa IVD Infectious Diseases Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa IVD Infectious Diseases Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa IVD Infectious Diseases Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa IVD Infectious Diseases Market Size by Country (2022-2027) & (US$ Million) Table 61. BD Company Details Table 62. BD Business Overview Table 63. BD IVD Infectious Diseases Product Table 64. BD Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 65. BD Recent Development Table 66. BioMerieux Company Details Table 67. BioMerieux Business Overview Table 68. BioMerieux IVD Infectious Diseases Product Table 69. BioMerieux Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 70. BioMerieux Recent Development Table 71. Abbott Company Details Table 72. Abbott Business Overview Table 73. Abbott IVD Infectious Diseases Product Table 74. Abbott Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 75. Abbott Recent Development Table 76. Quidel Company Details Table 77. Quidel Business Overview Table 78. Quidel IVD Infectious Diseases Product Table 79. Quidel Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 80. Quidel Recent Development Table 81. Gen-Probe Company Details Table 82. Gen-Probe Business Overview Table 83. Gen-Probe IVD Infectious Diseases Product Table 84. Gen-Probe Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 85. Gen-Probe Recent Development Table 86. Abbott Company Details Table 87. Abbott Business Overview Table 88. Abbott IVD Infectious Diseases Product Table 89. Abbott Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 90. Abbott Recent Development Table 91. Danaher Company Details Table 92. Danaher Business Overview Table 93. Danaher IVD Infectious Diseases Product Table 94. Danaher Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 95. Danaher Recent Development Table 96. Sysmex Company Details Table 97. Sysmex Business Overview Table 98. Sysmex Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 99. Sysmex Recent Development Table 100. Orasure Company Details Table 101. Orasure Business Overview Table 102. Orasure IVD Infectious Diseases Product Table 103. Orasure Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 104. Orasure Recent Development Table 105. Hologic Company Details Table 106. Hologic Business Overview Table 107. Hologic IVD Infectious Diseases Product Table 108. Hologic Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 109. Hologic Recent Development Table 110. Cepheid Company Details Table 111. Cepheid Business Overview Table 112. Cepheid IVD Infectious Diseases Product Table 113. Cepheid Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 114. Cepheid Recent Development Table 115. Qiagen Company Details Table 116. Qiagen Business Overview Table 117. Qiagen IVD Infectious Diseases Product Table 118. Qiagen Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 119. Qiagen Recent Development Table 120. Roche Diagnostics Company Details Table 121. Roche Diagnostics Business Overview Table 122. Roche Diagnostics IVD Infectious Diseases Product Table 123. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 124. Roche Diagnostics Recent Development Table 125. Siemens Healthcare Company Details Table 126. Siemens Healthcare Business Overview Table 127. Siemens Healthcare IVD Infectious Diseases Product Table 128. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 129. Siemens Healthcare Recent Development Table 130. Bio-Rad Laboratories Company Details Table 131. Bio-Rad Laboratories Business Overview Table 132. Bio-Rad Laboratories IVD Infectious Diseases Product Table 133. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2016-2021) & (US$ Million) Table 134. Bio-Rad Laboratories Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global IVD Infectious Diseases Market Share by Type: 2020 VS 2027 Figure 2. Immunochemistry Features Figure 3. Molecular Diagnostics Features Figure 4. Global IVD Infectious Diseases Market Share by Application: 2020 VS 2027 Figure 5. Clinical Laboratories Case Studies Figure 6. Diagnostic Centers Case Studies Figure 7. IVD Infectious Diseases Report Years Considered Figure 8. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 9. Global IVD Infectious Diseases Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global IVD Infectious Diseases Market Share by Regions: 2020 VS 2027 Figure 11. Global IVD Infectious Diseases Market Share by Regions (2022-2027) Figure 12. Global IVD Infectious Diseases Market Share by Players in 2020 Figure 13. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IVD Infectious Diseases as of 2020 Figure 14. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2020 Figure 15. Global IVD Infectious Diseases Revenue Market Share by Type (2016-2021) Figure 16. Global IVD Infectious Diseases Revenue Market Share by Type (2022-2027) Figure 17. North America IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 18. North America IVD Infectious Diseases Market Share by Type (2016-2027) Figure 19. North America IVD Infectious Diseases Market Share by Application (2016-2027) Figure 20. North America IVD Infectious Diseases Market Share by Country (2016-2027) Figure 21. United States IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. Canada IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Europe IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe IVD Infectious Diseases Market Share by Type (2016-2027) Figure 25. Europe IVD Infectious Diseases Market Share by Application (2016-2027) Figure 26. Europe IVD Infectious Diseases Market Share by Country (2016-2027) Figure 27. Germany IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. France IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. U.K. IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Italy IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Russia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Nordic IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Asia-Pacific IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific IVD Infectious Diseases Market Share by Type (2016-2027) Figure 35. Asia-Pacific IVD Infectious Diseases Market Share by Application (2016-2027) Figure 36. Asia-Pacific IVD Infectious Diseases Market Share by Region (2016-2027) Figure 37. China IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Japan IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. South Korea IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. India IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Australia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Latin America IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America IVD Infectious Diseases Market Share by Type (2016-2027) Figure 45. Latin America IVD Infectious Diseases Market Share by Application (2016-2027) Figure 46. Latin America IVD Infectious Diseases Market Share by Country (2016-2027) Figure 47. Mexico IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Brazil IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Middle East & Africa IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa IVD Infectious Diseases Market Share by Type (2016-2027) Figure 51. Middle East & Africa IVD Infectious Diseases Market Share by Application (2016-2027) Figure 52. Middle East & Africa IVD Infectious Diseases Market Share by Country (2016-2027) Figure 53. Turkey IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. UAE IVD Infectious Diseases Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. BD Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 57. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 58. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 59. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 60. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 61. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 62. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 63. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 64. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 65. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 66. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 67. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 68. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 69. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 70. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2016-2021) Figure 71. Bottom-up and Top-down Approaches for This Report Figure 72. Data Triangulation Figure 73. Key Executives Interviewed

BD BioMerieux Abbott Quidel Gen-Probe Abbott Danaher Sysmex Orasure Hologic Cepheid Qiagen Roche Diagnostics Siemens Healthcare Bio-Rad Laboratories